CBD Nutraceuticals Market Size, Share & Trends Analysis Report By Product (CBD Tinctures, Capsules & Softgels, CBD Gummies, Others), By Application (Edibles and Fortified Foods, Workout Supplements, Wellness, Others), By Sales Channel (Online Channel, Offline Channel) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

CBD Nutraceuticals Market Size

The global CBD nutraceuticals market size was valued at USD 9.34 billion in 2024 and is projected to reach from USD 10.54 billion in 2025 to USD 37.45 billion by 2033, exhibiting a CAGR of 14.78% during the forecast period (2025-2033). 

CBD nutraceuticals are health and wellness products that contain cannabidiol, a non-psychoactive compound derived from the hemp plant. These products are gaining traction in the nutraceutical market due to their perceived health benefits, which include anti-inflammatory properties, anxiety relief, and support for overall well-being. As the market enters a dynamic growth phase, consumer interest in natural wellness solutions continues to rise, alongside a broader acceptance of hemp-derived products.

Brands are innovating beyond traditional offerings like oils and capsules, introducing a diverse range of CBD-infused products that cater to various lifestyle preferences. This includes Cannabidiol beverages, workout supplements, edibles, skincare items, and even pet care products. Such diversification not only meets the growing consumer demand for variety but also enhances the integration of CBD into daily wellness routines, making it more accessible and appealing to a wider audience.

Furthermore, as consumers become increasingly health-conscious, they seek out products that align with their wellness goals, leading to greater experimentation with Cannabidiol in different forms. This trend is also supported by ongoing research highlighting the potential therapeutic benefits of Cannabidiol, fueling interest from both consumers and manufacturers. As a result, the CBD nutraceuticals industry is poised for continued growth, driven by innovation, consumer demand, and the evolving perception of hemp-derived products as a vital component of modern health and wellness.

CBD Nutraceuticals Market Trends

Rising demand for plant-based products

The increasing demand for plant- and herbal-based products is a key market trend supporting the growth of Cannabidiol nutraceuticals as consumers seek natural remedies that align with holistic wellness values. This shift is evident among those looking for alternatives to conventional medications, with CBD-infused supplements like gummies and capsules gaining popularity as perceived safer options.

Health-conscious lifestyles further support the acceptance of Cannabidiol for overall well-being. Therefore, brands such as Charlotte's Web, Inc. and Elixinol launched a variety of CBD oils for both human and animal health.

• For example, in November 2023, Charlotte's Web introduced a pet product containing 17 mg of plant-based cannabinoids per 1 ml, available in both unflavored and chicken-flavored options.

This innovative approach highlights the expanding application of CBD in various consumer segments, from pets to humans, showcasing the versatility of Cannabidiol nutraceuticals. 

Adoption of CBD nutraceuticals in mainstream healthcare

CBD nutraceuticals are increasingly being recognized within mainstream healthcare, particularly in regions with established health systems. Healthcare professionals, including nutritionists and wellness practitioners, are actively recommending Cannabidiol products as part of holistic health strategies.

• In the U.S., many healthcare providers are integrating CBD nutraceuticals into patient wellness plans, acknowledging their potential benefits for managing conditions like anxiety and chronic pain.
• In Germany, the acceptance of CBD nutraceuticals has grown, with increasing numbers of pharmacies offering a range of Cannabidiol products, reflecting a broader acknowledgment of their role in promoting health and well-being.

This shift is fueled by heightened awareness among healthcare professionals regarding the benefits of CBD, coupled with enhanced education about its therapeutic uses, which supports its integration into routine wellness practices.

CBD Nutraceuticals Market Growth Factors

Rising focus on noncommunicable diseases

The increasing adoption of Cannabidiol for managing non-communicable diseases (NCDs) underscores its therapeutic potential. Conditions such as chronic pain, insomnia, Alzheimer’s disease, and arthritis are becoming more prevalent, prompting patients to explore alternative treatments. Research has shown that CBD may offer relief for chronic pain by interacting with the body’s endocannabinoid system, helping to reduce inflammation and improve overall comfort.

• For instance, in August 2024, a report from the Indian Journal of Medical Ethics stated that PureKana CBD gummies are a popular choice among patients seeking relief from various conditions, including chronic pain, anxiety, and insomnia.

This growing interest in Cannabidiol for NCD management is driving market expansion as consumers increasingly view it as a viable therapeutic option.

Improved regulatory landscape

The rising popularity of CBD and hemp-based products has led to significant changes in regulatory compliance worldwide. Many countries are actively legalizing these products, prompting the establishment of new regulatory bodies to oversee compliance requirements for businesses in this sector.

In the U.S., the Food and Drug Administration (FDA) has taken a proactive role in regulating Cannabidiol products. With CBD, derived from hemp, no longer classified as a controlled substance, the FDA faces growing pressure to ensure the safety and efficacy of products that incorporate Cannabidiol, including dietary supplements and additives.

• For instance, in February 2023, the U.S. National Health Agency approved CBD-derived products, such as Epidiolex, for medical use, marking a significant step in regulatory acceptance.

This shift not only enhances consumer confidence in Cannabidiol nutraceuticals but also encourages investment and innovation in the market, further fueling its growth.

Market Restraints

Limited insurance coverage for CBD nutraceuticals

The absence of insurance coverage for Cannabidiol nutraceuticals poses significant barriers to patient access, making these products costly and hindering their widespread adoption.

• In the UK, while CBD was legalized in 2018, coverage through the National Health Service (NHS) remains minimal and typically limited to severe cases or specific conditions, necessitating robust clinical evidence for approval.

• In the U.S., despite the increasing popularity of CBD nutraceuticals, most health insurance plans do not reimburse for these products, leading to high out-of-pocket expenses that may discourage consumers from using them.

Consequently, insurance companies and healthcare systems are often hesitant to cover Cannabidiol nutraceuticals, primarily due to concerns regarding their efficacy and a lack of comprehensive clinical data, which perpetuates high costs and restricts patient access, ultimately slowing market growth.

Market Opportunities

Educational campaigns to normalize CBD use in regions lacking acceptance

In regions like Albania, Andorra, Belarus, Japan, South Korea, and Singapore, the acceptance of cannabinoids as dietary supplements remains limited. This gap in market acceptance presents a significant opportunity for companies to implement educational campaigns aimed at informing consumers about the benefits and applications of Cannabidiol.

By enhancing awareness and understanding of CBD's potential health benefits, businesses can help normalize its use as a dietary supplement. Such initiatives can drive demand and foster consumer trust and confidence in Cannabidiol products.

• For instance, the European Industrial Hemp Associationhas launched educational programs in various European countries, providing information on the legal status, health benefits, and safety of hemp-derived products.

This approach not only educates consumers but also engages healthcare professionals, encouraging them to recommend CBD as a therapeutic option.

Regional Insights

North America: Dominant region with a 54.5% share in the CBD Nutraceuticals Market

North America holds a leading position in the global market, driven by rising consumer awareness and the increasing adoption of Cannabidiol in various applications. Supportive regulatory environments in the U.S. and Canada, along with a robust healthcare infrastructure and active R&D centers, have further fueled growth, particularly in foods, cosmetics, and medicines.

Furthermore, key players include CV Sciences, Charlotte's Web, Inc., and Elixinol, which are focusing on innovative product development and expanding their product lines to meet consumer demand. For instance,

• In May 2024, CV Sciences, Inc. acquired Elevated Softgels for USD 1 million to improve production flexibility and accelerate product development. This acquisition aims to boost sales and streamline manufacturing of its +PlusCBD products, a key revenue driver.

• In March 2024, CV Sciences, Inc. launched new Cannabidiol chews for pets, including +PlusCBD Pet Hip and Joint Health Chews and +PlusCBD Pet Calming Care Chews.

• In January 2023, CV Sciences, Inc. introduced a 30-count bottle of its +PlusCBD Reserve Collection Softgels, offering a cost-effective option for consumers. The softgels feature a 10:1 CBD to THC ratio for effective stress and anxiety relief.Bottom of Form

Europe: Fastest growing region with the highest market CAGR

The European region is projected to experience the fastest growth in the Cannabidiol nutraceuticals market, fueled by the rising prevalence of chronic health disorders, increased awareness of CBD's benefits, and improved product availability.

• For example, Alzheimer Europe estimates that dementia cases in the region could reach 18.8 million by 2050. The growing incidence of Alzheimer’s disease is expected to drive demand for Cannabidiol due to its potential to manage symptoms related to neurodegenerative conditions, such as anxiety and sleep disturbances.

This increasing need for effective health solutions among an aging population further supports market expansion in Europe, creating ample opportunities for companies to innovate and develop products tailored to this demographic.Bottom of Form

Country Insights

The market is experiencing significant growth globally, influenced by varying regulatory landscapes, consumer acceptance, and market dynamics across different countries. Key regions are embracing CBD products, leading to diverse opportunities for market players.

Below is the analysis of key countries impacting the market:

• U.S.- The U.S. market led the industry, capturing the largest revenue share in 2023. As reported by the National Conference of State Legislatures in June 2023, 24 states and the District of Columbia have enacted laws regulating adult use of cannabis for non-medical purposes.Moreover, the growing acceptance of Cannabidiol products, a wide range of available brands, and increased accessibility through online platforms are driving the market's growth.
• Canada- The growing acceptance of cannabis for medical use is significantly impacting the Cannabidiol nutraceuticals market in Canada. As consumers become more educated and engaged with cannabis-related health products, demand is likely to rise.For instance, in March 2024, the number of individuals registered with Health Canada for personal and designated cultivation of cannabis for medical purposes increased by 15%, from 13,672 in December 2023 to 15,726. This trend suggests a broader shift toward cannabis integration in health and wellness.
• India- India is making strides in the CBD nutraceutical market with the launch of cannabis research projects. For instance, in June 2023, the CSIR-IIIM Jammu initiated its first “Cannabis Research Project,” aimed at developing export-quality medicines and supplements for conditions such as neuropathies, cancer, and epilepsy.This project, backed by a partnership with IndusScan, is set to boost local production and reduce reliance on imported medicines, showcasing India's growing commitment to medical cannabis research and innovation.
• China: China's CBD nutraceuticals industry is expected to grow over the forecast period, fueled by rising healthcare initiatives and increased disposable income. As the economy grows, consumers are more willing to invest in health and wellness products.Moreover, the aging population is driving demand for Cannabidiol solutions, particularly for pain relief, with popular formats like tinctures, capsules, and softgels.
• Japan: Japan is emerging as a key market for CBD products, driven by increasing consumer interest in health and wellness. For instance, in April 2024, CBD brand CURE announced plans to launch its CBD-focused functional beverages and dietary supplements in Japan. The company is adapting its products to meet local regulatory requirements while retaining its proprietary Cannabidiol and herbal blends.CURE's offerings, including wellness shots, gummies, and sparkling water, aim to align with the fast-paced lifestyles of Japanese consumers.
• Germany: Germany's regulatory landscape for cannabis is evolving rapidly, creating new opportunities for the market. In April 2024, the country enacted the Cannabis Act, introducing a comprehensive framework for cannabis consumption while amending several existing laws, including the Medicinal Cannabis Act and the Narcotic Act.This significant legislative change is anticipated to greatly impact the Cannabidiol nutraceuticals market in Germany during the forecast period.
• UK- In the UK, various companies are implementing strategies to enhance the growth of Cannabidiol supplements. For instance, in February 2021, HemPoland, a subsidiary of The Green Organic Dutchman, launched CannabiGold Sport, a line of hemp-derived CBD pre- and post-workout supplements for athletes.This range includes five formulations with plant-derived ingredients and pure Cannabidiol, showcasing the brand's commitment to meeting the increasing demand for health and wellness solutions in sports.

Segmentation Analysis

The global market is segmented into product, application, and sales channels.

By Product

The global CBD nutraceuticals market is bifurcated into CBD tinctures, capsules & softgels, CBD gummies, and others.

The CBD tinctures segment dominates the market, generating the largest revenue driven by their versatility and rapid absorption. They are effective for conditions such as chronic pain, depression, and substance use disorders, making them highly appealing. With a wide range of concentrations and flavors, tinctures attract a broad audience.

Notable brands such as Charlotte's Web, Stirling CBD, and Elixinol offer diverse options for both humans and pets.

• For instance, in April 2023, Stirling CBD Oil launched a new line of high-quality Cannabidiol tinctures made from organic hemp extract, targeting stress reduction, pain relief, and improved sleep.

By Application

The global market is segmented into edibles and fortified foods, workout supplements, wellness, and others.

The wellness segment dominates the market, holding the largest market revenue driven by rising health consciousness and preferences for plant-based products. Consumers are seeking organic and natural alternatives to conventional options. Moreover, busy lifestyles and extensive work hours contribute to the demand for CBD wellness products. The variety, such as capsules, supplements, soft gels, and tinctures, broadens the consumer base.

• For instance, in January 2022, Martha Stewart CBD expanded its line with wellness topicals, including Super Strength CBD Cream for muscle recovery, Sleep Science CBD Cream for better sleep, and Daily De-Stress CBD Cream for stress management.

By Sales Channel

The global market for CBD nutraceuticals is divided into online channels and offline channels.

The online segment dominates the market, driven by convenience and a broad product selection. Consumers increasingly favor online shopping for its ability to provide detailed product information, customer reviews, and competitive pricing. This preference is further fueled by the growing acceptance of e-commerce platforms as a reliable shopping channel for health and wellness products.

Key growth factors include a rising preference for e-commerce, which allows consumers to explore diverse Cannabidiol offerings ranging from oils and gummies to skincare and pet products, all from the comfort of their homes. Moreover, many online retailers offer extra services such as doorstep delivery and expert assistance, which enhance the overall shopping experience.

Company Market Share

Prominent players in the Cannabidiol nutraceuticals market include Charlotte's Web, Elixinol, Medical Marijuana, Inc., and CV Sciences, among others, which are competing for valuable market insights. As competition intensifies, these companies are focusing on innovation, expanding distribution, forming partnerships, and enhancing their product portfolios to attract a broader consumer base.

Dsm-Firmenich: An emerging player in the Cannabidiol nutraceuticals market

Dsm-Firmenich is leading the way in the dynamic Cannabidiol sector. As a dependable, purpose-driven partner, the company provides a wide range of science-based products and tailored solutions backed by expert services specifically designed to foster Cannabidiol innovation in the pharmaceutical market.

Recent developments at Dsm-Firmenich include:

• In June 2024, Dsm-Firmenich launched CBtru, an advanced formulated cannabidiol drug product intermediate specifically designed for oral solid delivery formats. This IP-protected innovation offers superior functionality, allow

Analyst Opinion

As per our analyst, the CBD nutraceutical market has undergone rapid evolution in recent years, propelled by a significant increase in consumer awareness regarding its health benefits. The entry of major players into the market signifies a maturation phase characterized by heightened competition, which is likely to drive improvements in product quality and standardization across the industry.

Moreover, the emergence of a clearer regulatory landscape is instilling stability for investors and fostering greater confidence in market dynamics. As regulations become more established, we can anticipate the development of broader distribution channels, positioning the industry for sustained growth and expanded market opportunities in the future.

Recent Developments

• May 2024 - CV Sciences, Inc. acquired Elevated Softgels for USD 1 million, a strategic move aimed at boosting production flexibility and expediting new product development. This acquisition supports CV Sciences' ability to respond swiftly to market demand, streamline manufacturing, and advance its +PlusCBD product line, strengthening its position in the CBD nutraceuticals market and enhancing its capacity to deliver high-quality, innovative products.